Work

Evaluation of Biosimilars for Formulary Inclusion: Factors for Consideration by P&T Committees.

Year: 2015
Type: article
Abstract: P&T committees will play a key role in driving the adoption of biosimilars, which have unique characteristics compared with small-molecule generic drugs. Key elements of formulary review will include clinical parameters, product characteristics, and institutional considerations, which are among the issues covered in this article.
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W1936638656
FWCI: 0.615
Cites: 20
Cited by: 22
Related to: 10